---
title: "SNTI.US (SNTI.US) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/SNTI.US/news.md"
symbol: "SNTI.US"
name: "SNTI.US"
parent: "https://longbridge.com/zh-HK/quote/SNTI.US.md"
datetime: "2026-03-12T17:53:06.232Z"
locales:
  - [en](https://longbridge.com/en/quote/SNTI.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SNTI.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SNTI.US/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/SNTI.US/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/SNTI.US/news.md)


# SNTI.US (SNTI.US) — 相關新聞

### [Senti Bio joins Cell & Gene Live event showcasing new technologies for cell therapy. Nasdaq: SNTI.](https://longbridge.com/zh-HK/news/276451072.md)
*2026-02-20T13:51:23.000Z*
> In South San Francisco on February 20, 2026, Senti Biosciences, Inc. (Nasdaq: SNTI), a clinical-stage biotechnology firm

### [Senti Bio Participates in Cell & Gene Live Event Highlighting Cutting-Edge Technologies Advancing Cell Therapy Development | SNTI Stock News](https://longbridge.com/zh-HK/news/276449720.md)
*2026-02-20T05:50:00.000Z*
> Senti Biosciences, Inc. (Nasdaq: SNTI) participated in the Cell & Gene Live virtual event on February 19, 2026, discussi

### [Lu Chaoqun's son becomes a leader in gene therapy, Lu Guanda Biotechnology Company listed in the U.S](https://longbridge.com/zh-HK/news/276191778.md)
*2026-02-18T02:32:06.000Z*
> Lu Chaoqun's son Lu Guanda founded the biotech company SentiBio in the United States and successfully listed on Nasdaq, 

### [Patient enrolment concludes in Senti Biosciences’ SENTI-202 Phase I trial](https://longbridge.com/zh-HK/news/275740471.md)
*2026-02-12T10:33:22.000Z*
> Senti Biosciences has completed patient enrolment in its Phase I trial for SENTI-202, a CAR NK cell therapy targeting re

### [Senti Biosciences Completes Phase 1 Enrollment for SENTI-202 in Relapsed or Refractory AML](https://longbridge.com/zh-HK/news/275613498.md)
*2026-02-11T13:35:10.000Z*
### [Senti Biosciences to Present Gene Circuit Platform at Healthcare Conference Taipei](https://longbridge.com/zh-HK/news/274668813.md)
*2026-02-03T14:00:19.000Z*
### [Senti Biosciences CEO Highlights AML Breakthroughs and RMAT Status at Virtual Investor Event](https://longbridge.com/zh-HK/news/272566937.md)
*2026-01-14T14:15:11.000Z*
### [Senti Bio joins panel at Biotech Showcase during J.P. Morgan Healthcare Conference on Jan 13th at 8:00 AM PT.](https://longbridge.com/zh-HK/news/272089571.md)
*2026-01-09T13:56:35.000Z*
> A live panel presentation is scheduled to take place on Tuesday, January 13th at 8:00 AM PT.